A New Technique for Endoscopic Implantation and Explantation of Large-bore Biliary Endoprostheses in Patients with Non-surgical Common Bile Duct Obstruction

Thon, H.-J.; Lerch, Markus M.; Matern, Siegfried

doi:10.1055/s-2007-1018286

Cited by 6 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients were treated for six months but underwent scheduled re‐ERCP after three months even in the fcSEMS group, which may not be necessary (and may even obviate the advantage of fcSEMS treatment versus PS) given the favorable three‐month patency for fcSEMS reported in most studies. Taken together these data suggest that the previous preference for PS for benign and (covered) metal stents for malignant lesions 29 , 30 no longer holds and fully covered metal stents are increasingly and effectively making inroads into the realm of benign pancreaticobiliary strictures.…”

Section: Discussionmentioning

confidence: 90%

Effective treatment of benign biliary strictures with a removable, fully covered, self‐expandable metal stent: A prospective, multicenter European study

et al. 2017

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 90%

Effective treatment of benign biliary strictures with a removable, fully covered, self‐expandable metal stent: A prospective, multicenter European study

et al. 2017

View full text Add to dashboard Cite

show abstract

Pancreatic cancer — Palliative therapy: stenting

Wahnschaffe

Kraft

Turi

et al. 2007

Chinese German J Clin Oncol

View full text Add to dashboard Cite

Pancreatic cancer is the third most common cancer in the gastrointestinal tract and the fourth leading cause of cancer death in most western or industrialized countries [1] . Over 95% of pancreatic malignancies originate in the pancreatic ducts and are adenocarcinomas by histology. The 5-year survival rate is < 5%, and of the 10%-20% of patients with resectable disease, only approximately 1 in 5 will survive the next 5 years. Despite great scientific effort and large increases in knowledge of the cellular events leading to pancreatic adenocarcinoma, survival rates have not changed significantly over the last 20 years. Furthermore, our understanding of the biology of this carcinoma, such as initiation, progression, and metastasis formation remains to be elusive. Only 5%-10% of all pancreatic adenocarcinomas have a clear hereditary association, and cigarette smoking, chronic pancreatitis and adult onset diabetes of less than two years' duration are the only consistently identified and modifiable risk factors [2][3][4]

show abstract

Recanalization of clogged biliary stent

Hsu¹

1990

Gastrointestinal Endoscopy

View full text Add to dashboard Cite

A New Technique for Endoscopic Implantation and Explantation of Large-bore Biliary Endoprostheses in Patients with Non-surgical Common Bile Duct Obstruction

Cited by 6 publications

References 0 publications

Effective treatment of benign biliary strictures with a removable, fully covered, self‐expandable metal stent: A prospective, multicenter European study

Effective treatment of benign biliary strictures with a removable, fully covered, self‐expandable metal stent: A prospective, multicenter European study

Pancreatic cancer — Palliative therapy: stenting

Recanalization of clogged biliary stent

Contact Info

Product

Resources

About